A general outline of the risk assessment process at the Center for Foo
d Safety and Applied Nutrition (CFSAN) of the Food and Drug Administra
tion based on the toxicologic evaluation of data is described. Example
s of recent pathology evaluations are presented to illustrate primaril
y the pathology review process at the CFSAN. These examples include th
e review of data from rodent studies from proposed indirect food addit
ives and data from dog studies submitted in support of an investigatio
nal new drug, a shea-acting opioid, proposed as an anesthetic in human
s.